Janus Henderson Group PLC Sells 513,344 Shares of CVS Health Corp (NYSE:CVS)
Janus Henderson Group PLC lowered its position in shares of CVS Health Corp (NYSE:CVS) by 32.0% in the first quarter, Holdings Channel reports. The fund owned 1,092,813 shares of the pharmacy operator’s stock after selling 513,344 shares during the period. Janus Henderson Group PLC’s holdings in CVS Health were worth $58,933,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in CVS. Bay Harbor Wealth Management LLC increased its position in CVS Health by 1,871.4% during the 1st quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 524 shares during the period. Acima Private Wealth LLC bought a new position in CVS Health during the 4th quarter worth $33,000. C J Advisory Inc bought a new position in CVS Health during the 1st quarter worth $33,000. Murphy Pohlad Asset Management LLC bought a new position in CVS Health during the 4th quarter worth $39,000. Finally, Somerset Trust Co increased its position in CVS Health by 152.7% during the 1st quarter. Somerset Trust Co now owns 758 shares of the pharmacy operator’s stock worth $41,000 after buying an additional 458 shares during the period. 77.48% of the stock is owned by hedge funds and other institutional investors.
Several research firms have weighed in on CVS. Mizuho set a $71.00 price objective on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, June 5th. CIBC reiterated a “market perform” rating on shares of CVS Health in a research report on Monday, April 15th. Raymond James lowered their price objective on CVS Health from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a research report on Thursday, April 18th. BMO Capital Markets began coverage on CVS Health in a research report on Wednesday, April 10th. They set an “outperform” rating and a $58.00 price objective on the stock. Finally, SunTrust Banks lowered their price objective on CVS Health from $85.00 to $65.00 in a research report on Wednesday, April 10th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $76.48.
CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.62 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.50 by $0.12. The firm had revenue of $61.65 billion during the quarter, compared to the consensus estimate of $60.39 billion. CVS Health had a positive return on equity of 16.80% and a negative net margin of 0.08%. The company’s quarterly revenue was up 34.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.48 earnings per share. On average, equities analysts anticipate that CVS Health Corp will post 6.85 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.watchlistnews.com/janus-henderson-group-plc-sells-513344-shares-of-cvs-health-corp-nysecvs/3039209.html.
About CVS Health
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Featured Article: How Do You Calculate Return on Investment (ROI)?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.